| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2006 | ||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 8,5 M € | -1.5% | 8,6 M € | +1.9% | 8,5 M € | -4.4% | 8,9 M € | +20.3% | 7,4 M € | -0.9% | 7,4 M € | -3.4% | 7,7 M € | +2.3% | 7,5 M € | +0.8% | 7,5 M € | -5.6% | 7,9 M € | +2.6% | 7,7 M € | +2.4% | 7,5 M € | +4.4% | 7,2 M € | +5.4% | 6,8 M € | +16.2% | 5,9 M € | +5.0% | 5,6 M € | -17.8% | 6,8 M € | |
| EBITDA | 739,4 k € | +29.2% | 572,3 k € | +7.7% | 531,4 k € | +4.6% | 508,0 k € | +538.0% | 79,6 k € | -84.9% | 528,6 k € | -25.2% | 706,9 k € | -19.4% | 876,8 k € | +79.2% | 489,3 k € | -40.6% | 824,2 k € | +10.1% | 748,6 k € | +33.4% | 561,4 k € | +7.4% | 522,6 k € | +42.5% | 366,6 k € | -26.4% | 498,2 k € | +595.2% | -100,6 k € | -126.2% | 384,0 k € | |
| Operating profit | 567,8 k € | +17.4% | 483,6 k € | +9.4% | 442,2 k € | -4.8% | 464,3 k € | +346.5% | 104,0 k € | -75.9% | 432,3 k € | -35.5% | 669,9 k € | -18.8% | 825,4 k € | +206.3% | 269,5 k € | -64.4% | 756,3 k € | +12.2% | 674,0 k € | +21.2% | 556,1 k € | +7.4% | 517,8 k € | +108.5% | 248,3 k € | -18.6% | 305,2 k € | +400.7% | -101,5 k € | -140.4% | 251,2 k € | |
| Profit/loss | 399,6 k € | +38.1% | 289,5 k € | +8.3% | 267,3 k € | -9.6% | 295,7 k € | +630.9% | 40,5 k € | -84.2% | 256,4 k € | -36.0% | 400,3 k € | -22.3% | 515,1 k € | +233.1% | 154,6 k € | -68.5% | 490,5 k € | +15.0% | 426,6 k € | +31.9% | 323,5 k € | -8.9% | 355,2 k € | +146.9% | 143,9 k € | -35.8% | 224,2 k € | +253.5% | -146,0 k € | -237.7% | 106,0 k € | |
| Equity | 1,9 M € | +26.4% | 1,5 M € | +23.7% | 1,2 M € | +1.4% | 1,2 M € | -0.4% | 1,2 M € | -17.7% | 1,5 M € | -2.0% | 1,5 M € | -16.7% | 1,8 M € | -25.8% | 2,4 M € | +6.8% | 2,3 M € | -23.8% | 3,0 M € | +16.7% | 2,6 M € | +14.5% | 2,2 M € | +19.0% | 1,9 M € | +8.3% | 1,7 M € | +14.9% | 1,5 M € | +8.0% | 1,4 M € | |
| Total assets | 5,4 M € | +12.2% | 4,8 M € | +0.0% | 4,8 M € | +20.7% | 4,0 M € | +5.0% | 3,8 M € | +0.8% | 3,8 M € | -4.7% | 4,0 M € | -21.2% | 5,0 M € | +13.2% | 4,4 M € | +6.2% | 4,2 M € | -3.8% | 4,3 M € | +10.6% | 3,9 M € | -2.4% | 4,0 M € | +4.3% | 3,9 M € | +1.2% | 3,8 M € | +0.6% | 3,8 M € | -12.4% | 4,3 M € | |
| Cash | 86,9 k € | -70.8% | 297,0 k € | +32.6% | 224,0 k € | +175.1% | 81,4 k € | +289.9% | 20,9 k € | -92.9% | 296,2 k € | +23.2% | 240,4 k € | +16.3% | 206,7 k € | -72.2% | 744,0 k € | +30.7% | 569,3 k € | +82.3% | 312,4 k € | -1.5% | 317,2 k € | -43.8% | 564,1 k € | +33.0% | 424,0 k € | -33.5% | 637,9 k € | +71.7% | 371,5 k € | -41.3% | 633,0 k € | |
| Debts | 3,4 M € | +6.0% | 3,2 M € | -8.1% | 3,5 M € | +30.3% | 2,7 M € | +7.9% | 2,5 M € | +13.2% | 2,2 M € | -6.1% | 2,3 M € | -24.4% | 3,1 M € | +64.6% | 1,9 M € | +6.2% | 1,8 M € | +46.6% | 1,2 M € | -0.3% | 1,2 M € | -24.8% | 1,6 M € | -10.2% | 1,8 M € | -5.5% | 1,9 M € | -9.3% | 2,1 M € | -23.3% | 2,7 M € | |
| Staff | 21,8 | 24,6 | 23,1 | 24,8 | 26,8 | 24,4 | 26,1 | 27,9 | 29,4 | 29,9 | 29,2 | 28,9 | 29,3 | 29,3 | 26 | 25,4 | 33,3 | |||||||||||||||||
Public limited company · Wavre · incorporated on 23/12/1943 · 21,8 ETP
Public limited company profitable and well capitalised. Cash position declining (-70.8%).
Solid counterparty for a standard engagement.
ARKOPHARMA BELUX is a Public limited company incorporated in 1943. Its main activity is: Wholesale of pharmaceutical goods. Its registered office is in Wavre. It employs on average 21,8 ETP workers (FTE).
Key indicators
7-day free trial, no credit card required.
7-day free trial, no credit card required.
7-day free trial, no credit card required.
Source: Belgian Official Gazette